DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 int cells

Environmental and Molecular Mutagenesis

Volumn 51, Issue 4, 2010, Pages 304-314

  Attene Ramos, Matias S ^a   Nava, Gerardo M ^a   Muellner, Mark G ^a   Wagner, Elizabeth D ^a   Plewa, Michael J ^a   Gaskins, H Rex ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Colorectal cancer; Comet assay; Genotoxicity; Hydrogen sulfide; Single cell gel electrophoresis; Sulfate reducing bacteria; Toxicogenomics

Indexed keywords

HYDROGEN SULFIDE; MUTAGENIC AGENT;

ARTICLE; BACTERIAL METABOLISM; CELL CYCLE PROGRESSION; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; GENE EXPRESSION; GENOTOXICITY; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICOGENETICS; UPREGULATION; CELL LINE; CYTOLOGY; DRUG EFFECT; INTESTINE MUCOSA; METABOLISM;

BACTERIA (MICROORGANISMS);

CELL LINE; COMET ASSAY; DNA DAMAGE; GENE EXPRESSION; HUMANS; HYDROGEN SULFIDE; INTESTINAL MUCOSA; MUTAGENS;

EID: 77951626542     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20546     Document Type: Article

References (82)

1. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897-1906
2. Al-Salihi MA, Terrece Pearman A, Doan T, Reichert EC, Rosenberg DW, Prescott SM, Stafforini DM, Topham MK. 2009. Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Lett 273:225-232.
3. Arikawa E, Quellhorst G, Han Y, Yang J, Pan H, Yang J. 2006. PCR Array: A Simple and Quantitative Method for Gene Expression Profiling. Frederick, MD: SuperArray Bioscience Corp. Report nr White Paper 1. pp 1-11.
4. Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR. 2006. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4:9-14.
5. Attene-Ramos MS, Wagner ED, Gaskins HR, Plewa MJ. 2007. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res 5:455-459.
6. Babidge W, Millard S, Roediger W. 1998. Sulfides impair short chain fatty acid b-oxidation at acyl-CoA dehydrogenase level in colonocytes: Implications for ulcerative colitis. Mol Cell Biochem 181:117-124.
7. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R. 2007. NCBI GEO: Mining tens of millions of expression profiles - Database and tools update. Nucleic Acids Res 35(Database issue):D760-D765.
8. Beerens H, Romond C. 1977. Sulfate-reducing anaerobic bacteria in human feces. Am J Clin Nutr 30:1770-1776.
9. Benson FE, Stasiak A, West SC. 1994. Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J 13:5764-5771.
10. Box GEP, Hunter WG, Hunter JS. 1978. Statistics for Experimenters: An Introduction to Design, Data Analysis and Model Building. New York, NY:Wiley.
11. Breitling R, Armengaud P, Amtmann A, Herzyk P. 2004. Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83-92.
12. Breivik J, Gaudernack G. 1999. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 9:245-254.
13. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL, Hull MA. 2000. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156:545-553.
14. Christl SU, Eisner HD, Dusel G, Kasper H, Scheppach W. 1996. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: A potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci 41:2477-2481.
15. de la Chapelle A. 2004. Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780.
16. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3.
17. Deplancke B, Gaskins HR. 2003. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 17:1310-1312.
18. Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR. 2003. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp Biol Med (Maywood) 228:424-433.
19. Dickinson DA, Warnes GR, Quievryn G, Messer J, Zhitkovich A, Rubitski E, Aubrecht J. 2004. Differentiation of DNA reactive and non-reactive genotoxic mechanisms using gene expression profile analysis. Mutat Res 549:29-41.
20. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
21. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210.
22. Ellinger-Ziegelbauer H, Fostel JM, Aruga C, Bauer D, Boitier E, Deng S, Dickinson D, Le Fevre AC, Fornace AJ Jr, Grenet O, Gu Y, Hoflack JC, Shiiyama M, Smith R, Snyder RD, Spire C, Tanaka G, Aubrecht J. 2009. Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms. Toxicol Sci 110:341-352.
23. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
24. Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino G, Wallace JL. 2005. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129:1210-1224.
25. Florin T, Neale G, Gibson GR, Christl SU, Cummings JH. 1991. Metabolism of dietary sulphate: Absorption and excretion in humans. Gut 32:766-773.
26. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316.
27. Gibson GR, Cummings JH, Macfarlane GT. 1991. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Lett 86:103-111.
28. Goedecke W, Eijpe M, Offenberg HH, van Aalderen M, Heyting C. 1999. Mre11 and Ku70 interact in somatic cells, but are differentially expressed in early meiosis. Nat Genet 23:194-198.
29. Gorbach SL. 1982. The intestinal microflora and its colon cancer connection. Infection 10:379-384.
30. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
31. Harrison JC, Haber JE. 2006. Surviving the breakup: The DNA damage checkpoint. Annu Rev Genet 40:209-235.
32. Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
33. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. 2006. RankProd: A bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22:2825-2827. (Pubitemid 44742407)
34. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
35. Huycke MM, Gaskins HR. 2004. Commensal bacteria, redox stress, and colorectal cancer: Mechanisms and models. Exp Biol Med (Maywood) 229:586-597.
36. Jackson SP. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696. (Pubitemid 34567505)
37. Kanazawa K, Konishi F, Mitsuoka T, Terada A, Itoh K, Narushima S, Kumemura M, Kimura H. 1996. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 77(8 Suppl):1701-1706.
38. Khanna KK, Jackson SP. 2001. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 27:247-254. (Pubitemid 32201842)
39. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
40. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P. 1991. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639.
41. Le Fevre AC, Boitier E, Marchandeau JP, Sarasin A, Thybaud V. 2007. Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res 619:16-29. (Pubitemid 46602443)
42. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267:25934-25938. (Pubitemid 23013998)
43. Leschelle X, Goubern M, Andriamihaja M, Blottiere HM, Couplan E, Gonzalez-Barroso MD, Petit C, Pagniez A, Chaumontet C, Mignotte B, Bouillaud F, Blachier F. 2005. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim Biophys Acta 1725:201-212.
44. Levine J, Ellis CJ, Furne JK, Springfield J, Levitt MD. 1998. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93:83-87.
45. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. 1999. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 104:1107-1114. (Pubitemid 29536321)
46. Levitt MD, Springfield J, Furne J, Koenig T, Suarez FL. 2002. Physiology of sulfide in the rat colon: Use of bismuth to assess colonic sulfide production. J Appl Physiol 92:1655-1660.
47. Li L, Bhatia M, Moore PK. 2006. Hydrogen sulphide - A novel mediator of inflammation? Curr Opin Pharmacol 6:125-129.
48. Lindblom A. 2001. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13:63-69.
49. Magee EA, Richardson CJ, Hughes R, Cummings JH. 2000. Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am J Clin Nutr 72:1488-1494.
50. Marinoni JC, Roy R, Vermeulen W, Miniou P, Lutz Y, Weeda G, Seroz T, Gomez DM, Hoeijmakers JH, Egly JM. 1997. Cloning and characterization of p52, the fifth subunit of the core of the transcription/DNA repair factor TFIIH. EMBO J 16:1093-1102.
51. Muellner MG, Attene-Ramos MS, Hudson ME, Wagner ED, Plewa MJ. Human cell toxicogenomic analysis of bromoacetic acid: A regulated drinking water disinfection by-product. Environ Mol Mutagen (in press).
52. O'Banion MK, Sadowski HB, Winn V, Young DA. 1991. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266:23261-23267.
53. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. 1996. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809.
54. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
55. Phillips HJ. 1973. Dye exclusion tests for cell viability. In: Kruse PF, Patterson MJ, editors. Tissue Culture: Methods and Applications. New York: Academic Press. p 406.
56. Pitcher MCL, Beatty ER, Gibson GR, Cummings JH. 1995. Incidence and activities of sulphate-reducing bacteria in patients with ulcerative colitis. Gut 36:A63.
57. Plewa MJ, Kargalioglu Y, Vankerk D, Minear RA, Wagner ED. 2002. Mammalian cell cytotoxicity and genotoxicity analysis of drinking water disinfection by-products. Environ Mol Mutagen 40:134-142.
58. Plewa MJ, Wagner ED, Jazwierska P, Richardson SD, Chen PH, McKague AB. 2004. Halonitromethane drinking water disinfection byproducts: Chemical characterization and mammalian cell cytotoxicity and genotoxicity. Environ Sci Technol 38:62-68. (Pubitemid 38044735)
59. Plewa MJ, Wagner ED, Muellner MG, Hsu KM, Richardson SD. 2008. Comparative mammalian cell toxicity of N-DBPs and C-DBPs. In: Karanfil T, Krasner SW,Westerhoff P,Xie Y, editors. Occurrence, Formation, Health Effects and Control of Disinfection By-Products in Drinking Water. Washington, D.C.: American Chemical Society. pp 36-50.
60. Pochart P, Dore J, Lemann F, Goderel I, Rambaud JC. 1992. Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett 77:225-228.
61. Potter JD. 1999. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 91:916-932.
62. Quellhorst G, Prabhakar S, Han Y, Yang J. 2006. PCR Array: A simple and quantitative method for gene expression profiling. Frederick, MD: SuperArray Bioscience Corp.
63. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC. 2006. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 291:G288-G296. (Pubitemid 44024689)
64. Reardon JT, Ge H, Gibbs E, Sancar A, Hurwitz J, Pan ZQ. 1996. Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH. Proc Natl Acad Sci USA 93:6482-6487.
65. Reiffenstein RJ, Hulbert WC, Roth SH. 1992. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 32:109-134.
66. Rhodes JM, Campbell BJ. 2002. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8:10-16.
67. Roediger WE, Duncan A, Kapaniris O, Millard S. 1993. Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis. Gastroenterology 104:802-809.
68. Roediger WE, Moore J, Babidge W. 1997. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 42:1571-1579.
69. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. 2006. The RIN: An RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3.
70. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN. 2000. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology 118:337-345.
71. Shiekhattar R, Mermelstein F, Fisher RP, Drapkin R, Dynlacht B, Wessling HC, Morgan DO, Reinberg D. 1995. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374:283-287.
72. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. 2001. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822.
73. Sinicrope FA. 2006. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog 45:447-454.
74. Sinicrope FA. 2007. Sporadic colorectal cancer: An infectious disease? Gastroenterology 132:797-801.
75. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR. 1999. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 96:15121-15126.
76. Thun MJ, Namboodiri MM, Heath CW Jr. 1991. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596.
77. Wagner ED, Plewa MJ. 2009. Microplate-based comet assay. In: Dhawan A, Anderson D, editors. The Comet Assay in Toxicology. London: Royal Society of Chemistry. pp 79-97.
78. Wang X, Huycke MM. 2007. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132:551-661.
79. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. 2005. Colorectal cancer. Lancet 365:153-165.
80. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692-2696.
81. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. 2006. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20:2118-2120.
82. Zhi L, Ang AD, Zhang H, Moore PK, Bhatia M. 2007. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-κB pathway. J Leukoc Biol 81:1322-1332.